No capital raising required, unless its for further acquisitions or to purchase the remaining 50% of IBN in 2019. Short answer: Not for a year or 2 at least.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025